Investigating the potential effects of α-synuclein aggregation on susceptibility to chronic stress in a mouse Parkinson's disease model

被引:2
|
作者
Alwani, Anna [1 ]
Maziarz, Katarzyna [1 ]
Lyszczarz, Gabriela [1 ]
Jankowska-Kieltyka, Monika [1 ]
Roman, Adam [1 ]
Lyszczarz, Gabriela [1 ]
Er, Safak [2 ,3 ]
Barut, Justyna [1 ]
Barczyk-Woznicka, Olga [4 ]
Pyza, Elzbieta [4 ]
Kreiner, Grzegorz [1 ]
Nalepa, Irena [1 ]
Chmielarz, Piotr [1 ]
机构
[1] Polish Acad Sci, Maj Inst Pharmacol, Dept Brain Biochem, Smetna 12, PL-31343 Krakow, Poland
[2] Univ Helsinki, Drug Res Program, Fac Pharm, Helsinki, Finland
[3] Univ Helsinki, HiLIFE, Inst Biotechnol, Helsinki, Finland
[4] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Cell Biol & Imaging, Gronostajowa 9, PL-30387 Krakow, Poland
基金
芬兰科学院;
关键词
alpha-synuclein; Preformed fibrils; Parkinson's disease; Non-motor symptoms; Depression; Chronic stress; LEWY BODIES; DEPRESSIVE-LIKE; AMYGDALA; MICE; BODY; NEURODEGENERATION; COMPENSATION; PHENOTYPES; DEMENTIA; BEHAVIOR;
D O I
10.1007/s43440-023-00530-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Parkinson's disease (PD) is a motor disorder characterized by the degeneration of dopaminergic neurons, putatively due to the accumulation of alpha-synuclein (alpha-syn) in Lewy bodies (LBs) in Substantia Nigra. PD is also associated with the formation of LBs in brain areas responsible for emotional and cognitive regulation such as the amygdala and prefrontal cortex, and concurrent depression prevalence in PD patients. The exact link between dopaminergic cell loss, alpha-syn aggregation, depression, and stress, a major depression risk factor, is unclear. Therefore, we aimed to explore the interplay between sensitivity to chronic stress and alpha-syn aggregation.Methods Bilateral injections of alpha-syn preformed fibrils (PFFs) into the striatum of C57Bl/6 J mice were used to induce alpha-syn aggregation. Three months after injections, animals were exposed to chronic social defeat stress.Results alpha-syn aggregation did not affect stress susceptibility but independently caused increased locomotor activity in the open field test, reduced anxiety in the light-dark box test, and increased active time in the tail suspension test. Ex vivo analysis revealed modest dopaminergic neuron loss in the substantia nigra and reduced dopaminergic innervation in the dorsal striatum in PFFs injected groups. alpha-Syn aggregates were prominent in the amygdala, prefrontal cortex, and substantia nigra, with minimal alpha-syn aggregation in the raphe nuclei and locus coeruleus.Conclusions Progressive bilateral alpha-syn aggregation might lead to compensatory activity increase and alterations in emotionally regulated behavior, without affecting stress susceptibility. Understanding how alpha-syn aggregation and degeneration in specific brain structures contribute to depression and anxiety in PD patients requires further investigation.
引用
收藏
页码:1474 / 1487
页数:14
相关论文
共 50 条
  • [1] Investigating the potential effects of α-synuclein aggregation on susceptibility to chronic stress in a mouse Parkinson’s disease model
    Anna Alwani
    Katarzyna Maziarz
    Gabriela Burda
    Monika Jankowska-Kiełtyka
    Adam Roman
    Gabriela Łyszczarz
    Safak Er
    Justyna Barut
    Olga Barczyk-Woźnicka
    Elżbieta Pyza
    Grzegorz Kreiner
    Irena Nalepa
    Piotr Chmielarz
    Pharmacological Reports, 2023, 75 (6) : 1474 - 1487
  • [2] Effects of UCH-L1 on α-synuclein over-expression mouse model of Parkinson's disease
    Yasuda, Toru
    Nihira, Tomoko
    Ren, Yong-Ri
    Cao, Xu-Qing
    Wada, Keiichiro
    Setsuie, Rieko
    Kabuta, Tomohiro
    Wada, Keiji
    Hattori, Nobutaka
    Mizuno, Yoshikuni
    Mochizuki, Hideki
    JOURNAL OF NEUROCHEMISTRY, 2009, 108 (04) : 932 - 944
  • [3] α-Synuclein aggregation and Parkinson's disease:: Factors affecting the aggregation of α-synuclein
    Jin, L
    Yang, H
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2006, 33 (04) : 321 - 328
  • [4] Ergothioneine exerts neuroprotective effects in Parkinson's disease: Targeting α-synuclein aggregation and oxidative stress
    Gao, Wen
    Wang, Yang
    Wang, Fuhao
    Wu, Xinni
    Lu, Fuping
    Liu, Fufeng
    FOOD RESEARCH INTERNATIONAL, 2025, 201
  • [5] Reduced cerebral blood flow in an α-synuclein transgenic mouse model of Parkinson's disease
    Biju, K. C.
    Shen, Qiang
    Hernandez, Enrique Torres
    Mader, Michael J.
    Clark, Robert A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2020, 40 (12) : 2441 - 2453
  • [6] Neuroprotective effects of lithium on a chronic MPTP mouse model of Parkinson's disease via regulation of α-synuclein methylation
    Zhao, Qing
    Liu, Hui
    Cheng, Jiwei
    Zhu, Yudan
    Xiao, Qian
    Bai, Yu
    Tao, Jie
    MOLECULAR MEDICINE REPORTS, 2019, 19 (06) : 4989 - 4997
  • [7] Models of α-synuclein aggregation in Parkinson's disease
    Maria Giraldez-Perez, Rosa
    Antolin-Vallespin, Monica
    Dolores Munoz, Maria
    Sanchez-Capelo, Amelia
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [8] Aggregation and spread of synuclein in Parkinson's disease
    Bezard, Erwan
    Dehay, Benjamin
    M S-MEDECINE SCIENCES, 2022, 38 (01): : 45 - 51
  • [9] Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson's disease
    Kim, Changyoun
    Ojo-Amaize, Emmanuel
    Spencer, Brian
    Rockenstein, Edward
    Mante, Michael
    Desplats, Paula
    Wrasidlo, Wolf
    Adame, Anthony
    Nchekwube, Emeka
    Oyemade, Olusola
    Okogun, Joseph
    Chan, Michael
    Cottam, Howard
    Masliah, Eliezer
    JOURNAL OF NEUROINFLAMMATION, 2015, 12
  • [10] Inhibitory Role of β-Casein on the α-Synuclein Aggregation Associated with Parkinson's Disease In Vitro
    Shahraki, Sima
    Shojaei, Saeed
    Shojaei, Siroos
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2018, 24 (01) : 179 - 187